Mein Warenkorb

Tau

Tau Molekülinformation

Englischer NameMicrotubule-associated protein tauAnzahl der inverkehr gebrachten Arzneimittel1
Anzahl der klinischen Arzneimittel36Target-AliasMAPT,MTBT1,Paired helical filament-tau,MAPTL,Microtubule Associated Protein Tau,G Protein Beta1/Gamma2 Subunit-Interacting Factor 1,Protein Phosphatase 1, Regulatory Subunit 103,Neurofibrillary Tangle Protein,PHF-Tau,TAU,Microtubule-Associated Protein Tau, Isoform 4,Microtubule-Associated Protein Tau,PPP1R103,FTDP-17,MTBT2,DDPAC,MSTD,PPND,tau Proteins,MGC138549,FLJ31424
Höchste Forschungs- und EntwicklungsphaseApproved
Englischer NameMicrotubule-associated protein tau
Target-AliasMAPT,MTBT1,Paired helical filament-tau,MAPTL,Microtubule Associated Protein Tau,G Protein Beta1/Gamma2 Subunit-Interacting Factor 1,Protein Phosphatase 1, Regulatory Subunit 103,Neurofibrillary Tangle Protein,PHF-Tau,TAU,Microtubule-Associated Protein Tau, Isoform 4,Microtubule-Associated Protein Tau,PPP1R103,FTDP-17,MTBT2,DDPAC,MSTD,PPND,tau Proteins,MGC138549,FLJ31424
Anzahl der inverkehr gebrachten Arzneimittel1
Anzahl der klinischen Arzneimittel36
Höchste Forschungs- und EntwicklungsphaseApproved

Tau Molekülhintergrund

Tau is a microtubule-associated protein, which encodes by the MAPT gene that located on chromosome 17q21. Tau Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. Hyperphosphorylation of the tau protein (tau inclusions, pTau) can result in the self-assembly of tangles of paired helical filaments and straight filaments, which are involved in the pathogenesis of Alzheimer's disease, frontotemporal dementia, and other tauopathies.

Tau Molekülalias

DDPAC,FTDP-17,MAPT,MSTD,MTBT1,Tau,PHF-tau,TAU

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
BuntanetapANVS-405; ANVS-401Phase 3 ClinicalRaptor PharmaceuticalDown Syndrome; Chronic Traumatic Encephalopathy; Alzheimer Disease; Parkinson Disease; Cognitive Dysfunction; Frontotemporal Dementia
Details
Florzolotau (Aprinoia Therapeutics)[18F]PM-PBB3; APN-1607; 18F-PM-PBB3; 18F-APN-1607; [18F]APN-1607; [18F]MNI-958; APN-0000455; F0-PBB3; PM-PBB3Phase 3 ClinicalAprinoia Therapeutics LtdSupranuclear Palsy, Progressive; Nerve Degeneration; Alzheimer Disease; Cognitive Dysfunction; Diagnostic agents; Cognition Disorders
Details
E-2814E-2814Phase 3 ClinicalEisai Co LtdDementia; Alzheimer Disease
Details
Izaflortaucipir F-18PI-2620; 18F-PI-2620; [18F]PI-2620Phase 3 ClinicalPiramal, Ac Immune SaSupranuclear Palsy, Progressive; Brain Injuries, Traumatic; Opioid-Related Disorders; Frontotemporal Lobar Degeneration; Alzheimer Disease; Cognitive Dysfunction
Details
XTR-006XTR-006Phase 3 ClinicalBeijing Xiantong International Technology Co LtdTauopathies; Alzheimer Disease
Details
ZagotenemabLY-3303560Phase 2 ClinicalEli Lilly And CompanyAlzheimer Disease
Details
PosdinemabJNJ-3657; JNJ-63733657Phase 2 ClinicalJohnson & Johnson Innovative MedicineDementia; Alzheimer Disease; Cognitive Dysfunction
Details
[18F]GTP-1[18F]GTP-1Phase 2 ClinicalGenentech IncAlzheimer Disease
Details
[18F]THK-5105[18F]THK-5105Phase 2 ClinicalTohoku UniversityAlzheimer Disease
Details
ISIS-814907BIIB-080; ISIS-814907; IONIS-MAPTRx; ISIS-BIIB4Rx; IONIS-BIIB4RXPhase 2 ClinicalBiogen Inc, Ionis Pharmaceuticals IncDementia; Cognitive Dysfunction; Alzheimer Disease
Details
TilavonemabC2N-8E12; ABBV-8E12Phase 2 ClinicalC2n Diagnostics LlcSupranuclear Palsy, Progressive; Alzheimer Disease
Details
SemorinemabMTAU-9937A; MTAU9937A; RG-6100; RO7105705; RO-7105705Phase 2 ClinicalAc Immune SaAlzheimer Disease
Details
APN-1701[18F]AM-PBB3; 18F-AM-PBB3; APN-1701Phase 2 ClinicalNational Institute Of Radiological Sciences, Aprinoia Therapeutics LtdNerve Degeneration; Alzheimer Disease
Details
VY-TAU-01VY-TAU01; VY-TAU-01; VY-7523Phase 2 ClinicalVoyager Therapeutics IncAlzheimer Disease
Details
Anti-tau antibody (Prothena)PRX-005; BMS-986446Phase 2 ClinicalProthenaAlzheimer Disease; Frontotemporal Dementia
Details
BepranemabUCB-0107; RG6416Phase 2 ClinicalUcbSupranuclear Palsy, Progressive; Alzheimer Disease
Details
[18F]THK-5117[18F]THK-5117Phase 2 ClinicalTohoku UniversityAlzheimer Disease
Details
PNT-001PNT-001Phase 1 ClinicalBeth Israel Deaconess Medical CenterBrain Injuries, Traumatic; Alzheimer Disease
Details
ReS19-TReS19-TPhase 1 ClinicalRemyndAlzheimer Disease
Details
Mecripyrine HydrochlorideSCR-1693; Y-1A; Y-1Phase 1 ClinicalJiangsu Simcere Pharmaceutical Co Ltd, Yantai Yene Pharma Co Ltd, NeuroDawn Pharmaceutical Co LtdBrain Neoplasms; Alzheimer Disease
Details
Lu-AF87908Lu-AF87908; Lu-AF-87908Phase 1 ClinicalH. Lundbeck A/SAlzheimer Disease
Details
RDC-5RDC-5Phase 1 ClinicalChronos Therapeutics LtdAmyotrophic Lateral Sclerosis
Details
MC-1 (Lilly)MC-1 (Lilly)Phase 1 ClinicalEli Lilly And CompanyAlzheimer Disease
Details
OLX-07010OLX07010Phase 1 ClinicalOligomerix IncSupranuclear Palsy, Progressive; Alzheimer Disease; Dementia; Neurodegenerative Diseases
Details
ProtollinPhase 1 ClinicalAlzheimer Disease
Details
AB-19 (AUTOTAC Bio)AB-19 (AUTOTAC Bio)Phase 1 ClinicalAutotac Bio IncSupranuclear Palsy, Progressive
Details
AB-12 po (AUTOTAC Bio)AB-12 poPhase 1 ClinicalAutotac Bio IncAlzheimer Disease
Details
[89Zr]Zr-DFO-BIIB080[89Zr]Zr-DFO-ISIS-814907; [89Zr]Zr-DFOPhase 1 ClinicalBiogen Inc
Details
DA-7503DA-7503Phase 1 ClinicalDong-A ST Co Ltd
Details
LY-3954068LY3954068; LY-3954068Phase 1 ClinicalEli Lilly And CompanyAlzheimer Disease
Details
ADEL-Y01ADEL-Y01Phase 1 ClinicalOscotec Inc, ADEL IncTauopathies; Alzheimer Disease
Details
MK-2214MK-2214Phase 1 ClinicalMerck Sharp & Dohme LLCAlzheimer Disease
Details
APNmAb-005APNmAb-005Phase 1 ClinicalAprinoia Therapeutics LtdNerve Degeneration; Alzheimer Disease; Tauopathies
Details
NIO-752NIO-752Phase 1 ClinicalNovartis Pharma AgSupranuclear Palsy, Progressive; Alzheimer Disease; Cognitive Dysfunction; Neurodegenerative Diseases
Details
BEY-2153BEY-2153Phase 1 ClinicalBeyondbio IncAlzheimer Disease
Details
11C-PBB311C-PBB3ClinicalNational Institute Of Radiological SciencesAlzheimer Disease
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Flortaucipir F1818F-AV-1451; [F18]AV1451; LY3191748; F-18-AV-1451; [18F]-T-807; [3H]AV 1451; T807; [F-18]T807ApprovedSiemens Medical SolutionTauvidUnited StatesAlzheimer DiseaseAvid Radiopharmaceuticals Inc2020-05-28Dementia; Frontotemporal Dementia; Neurodegenerative Diseases; Cognition Disorders; Corticobasal degeneration; Diagnostic agents; Cognitive Dysfunction; Tauopathies; Parkinson Disease; Supranuclear Palsy, Progressive; Alzheimer Disease; Pick Disease of the Brain; Aphasia, Primary Progressive; Chronic Traumatic Encephalopathy; Brain Concussion; Brain Injuries, Traumatic; Depression; Brain Injuries
Details

Produktrezensionen

  • P***g2021-08-24
    5Menschen mögen
    I have purchased multiple antigens from ACRO for discovery projects and I have found that the quality of antigens purchased from Acro is great!! Acro has become by go to vendor when I am looking for quality antigens. In addition, Acro also provides an impressive range of formats for each antigens, including different tags. Not to mention, their customer service team is fantastic. Overall, a great company to work with.
  • Molekülinformation
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Produktrezensionen
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns